Alkermes Contract Pharma Services


45 years of providing outsourcing solutions to our partners


Who we are, what we do 

Alkermes Contract Pharma Services provides solid oral dosage product process development, scale-up and manufacturing services as well as sterile fill finish capabilities to the global pharmaceutical market. With over 45 years in the service business, we have assisted our blue chip list of partners in the successful launch of multiple products in all the major markets worldwide. Our experience and expertise in manufacturing is committed to providing you with your exact production needs, delivered to the highest quality standards and at a fair price.


Key Benefits

Contract pharma experience and expertise:

•          ​45+ year history in contract pharma manufacturing business with a proven track record


Experience supplying product worldwide to exacting standards

  • FDA/EMA-licensed sites in both Europe and U.S. – most recent FDA audits resulted in no 483s.
  • Authorized to supply to all other major territories including supply of product to Brazil, China and India.


Wide range of services sets us apart:

•          ​Effective, robust and swift technical transfers

•          Range of proven validated process improvement solutions

•          Licensed to manufacture controlled drugs

•          High potency scale-up and manufacturing to SafeBridge® Category 3B

•          Modern facilities with best in class systems

•          Competitive pricing

•          On-time delivery record

•          Exceptional compliance record

•          Excellent environmental, health and safety record 


Contact Details

 Alkermes Pharma Ireland Limited  Monksland  Athlone  Co. Westmeath  IRELAND

Contact Person: 

Fidelma Callanan Tel: +353 90 649 5126



Related resources

show more

Pharmaceutical Outsourcing - key success factors

Pharmaceutical Outsourcing - key success factors

Content provided by Alkermes Contract Pharma Services | 13-Jun-2012 | White Paper

It is now considered a sound strategic move by pharmaceutical companies, from big pharma to smaller players, to increasingly rely on outsourcing service...